Table 2.
Changes between baseline and month 24 in ETDRS level, by phenotype
| Phenotype | DR worsening | No change | DR improving | ||||
| ≥3 steps | 2 steps | 1 step | 1 step | 2 steps | ≥3steps | ||
| A, n (%) | 0 (0.0) | 4 (4.6) | 13 (14.9) | 40 (46.0) | 13 (14.9) | 1 (1.2) | 16 (18.4) |
| B, n (%) | 1 (2.2) | 0 (0.0) | 3 (6.7) | 30 (66.7) | 7 (15.6) | 0 (0.0) | 4 (8.9) |
| C, n (%) | 2 (11.8) | 4 (23.5) | 1 (5.9) | 8 (47.1) | 1 (5.9) | 0 (0.0) | 1 (5.9) |
| Total | 3 (2.0) | 8 (5.4) | 17 (11.4) | 78 (52.4) | 21 (14.1) | 1 (0.7) | 21 (14.1) |
DR, diabetic retinopathy; ETDRS, Early Treatment Diabetic Retinopathy Study.